Larimar Therapeutics has new leaders, including John B. Harlow, Jr. as President and COO.

Sep 29, 2026, 5:01 PM ETNew bossRead the original at SEC EDGAR

Neutral

Larimar appointed John B. Harlow, Jr. as president and chief operating officer.

LRMR · Larimar Therapeutics, Inc.

AI read · Neutral

The AI's read

Harlow’s past work leading commercial teams at drug companies could bring useful experience to Larimar. The filing reports no new drug or sales results, and lists a $560,000 yearly salary, a bonus target, and options for 800,000 shares. Those facts do not clearly change what the company can do.

Get alerts for LRMR

Follow Larimar Therapeutics, Inc. (LRMR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LRMR

Free on the App Store and Google Play, or on the web.